Brad L. Tade's most recent trade in Adma Biologics Inc was a trade of 9,838 Common Stock done at an average price of $18.4 . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adma Biologics Inc | Brad L. Tade | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.40 per share. | 26 Jun 2025 | 9,838 | 246,542 (0%) | 0% | 18.4 | 181,019 | Common Stock |
| Adma Biologics Inc | Brad L. Tade | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.78 per share. | 26 Feb 2025 | 5,280 | 256,380 (0%) | 0% | 15.8 | 83,318 | Common Stock |
| Adma Biologics Inc | Brad L. Tade | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 93,023 | 93,023 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Brad L. Tade | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 62,227 | 261,660 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Brad L. Tade | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 21.15 per share. | 22 Nov 2024 | 15,000 | 199,433 (0%) | 0% | 21.2 | 317,250 | Common Stock |
| Adma Biologics Inc | Brad L. Tade | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 115,100 | 115,100 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Brad L. Tade | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 72,400 | 214,433 (0%) | 0% | 0 | Common Stock |